MEMPHIS, Tenn., May 9, 2013 /PRNewswire-USNewswire/ -- Michael Dyer , Ph.D., a scientist at St. Jude Children's Research Hospital, has been selected as a Howard Hughes Medical Institute (HHMI) investigator. Dyer is one of 27 scientists nationwide chosen for the recognition from among 1,155 applicants. There are approximately 330 HHMI investigators in the United States, and Dyer will become the third of these investigators currently working at St. Jude.
Investigators selected for the program by HHMI are some of the country's top biomedical researchers, demonstrating creativity, innovation and excellence in their areas of study. Dyer is an expert in the fields of developmental neurobiology, cell cycle regulation, stem cell biology, developmental therapeutics and cancer genetics.
"Dr. Dyer's research has repeatedly overturned long-held beliefs in science, earning him great respect as a world-class scientist and as an innovator," said Dr. William E. Evans , St. Jude director and CEO. "Being selected as an HHMI investigator is a great honor for any scientist, and the additional funding it provides will accelerate Dr. Dyer's research and the impact he is having on the treatment of childhood cancers."
Dyer's contributions include a 2007 study that showed brain cells called neurons could still divide. The finding countered a century-old scientific belief that differentiated, or mature, nerve cells could not multiply and make new cells. In 2012, Dyer and his colleagues demonstrated that an unexpected mechanism was responsible for the rapid growth of an eye tumor called retinoblastoma.
Dyer is a member of the St. Jude Developmental Neurobiology department and co-leader of the Developmental Therapeutics for Solid Malignancies Program. He is also an investigator with the St. Jude Children's Research Hospital-Washington University Pediat
|SOURCE St. Jude Children's Research Hospital|
Copyright©2012 PR Newswire.
All rights reserved